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Objectives: Grain-based diets (GBDs) are widely used in rodent studies, but the lack of control 
of ingredients in GBDs and potential batch to batch variation limit their utility. Purified diets 
(PDs)—diets with known sources and quantities of all nutrients—offer solutions and permit 
investigators to control for diet, a major environmental factor, in rodent studies. However, mice 
fed a standard PD display abnormal gastrointestinal (GI) anatomy and greater adiposity 
compared to mice fed a GBD—Purina 5001. Interestingly, the addition of a soluble fiber (inulin) 
to PDs (which usually only contain the insoluble fiber cellulose) ameliorates these adverse 
effects. Yet, the impact of PDs modified with soluble fibers from mixed sources on GI anatomy 
and the intestinal microbiota has not been investigated. We therefore sought to identify a 
combination of fibers in PDs that best recapitulate the GI health and intestinal microbiota of 
mice fed a GBD, while also including an additional reference GBD (Teklad 2020SX).  
 
Methods: 7-week-old C57BL/6J male mice were individually housed and randomly assigned to 
a diet (two GBDs and four PDs with varying fiber composition) for 28 days. To assess changes 
in GI anatomy, small intestinal length, colon length, cecal weight, and colon weight were 
recorded at tissue harvest. Cecal contents, colon contents, and fecal pellets were collected for 
16S rRNA gene sequencing to compare microbial profiles across different GI niches and 
between diets using the Quantitative Insights Into Microbial Ecology 2 pipeline (QIIME 2) 
pipeline.  
 
Results: Consistent with published data, GI anatomy was altered in mice consuming PDs 
compared to GBDs. Microbiotas from mice fed any PD significantly differed from mice 
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consuming either GBD in all GI niches (p<0.05, ANOSIM). Microbiotas were distinct between 
mice fed either Purina 5001 or Teklad 2020SX GBDs (p<0.01, ANOSIM). Mice fed low soluble 
fiber PDs (≤ 25% soluble fiber) also produced significantly different microbial communities than 
mice fed high soluble PDs (≥ 75% soluble fiber) (ANOSIM, p<0.001). Unexpectedly, the 
microbial richness of mice decreased with increasing soluble fiber content in PDs. The relative 
abundance of Lactococcus spp. and the [Eubacterium] xylanophilum group were different 
between mice fed GBDs and PDs, while Romboutsia spp. had a higher relative abundance in 
mice fed low soluble fiber PDs compared to other diet groups.  
 
Conclusions: Mice fed PDs with high soluble fiber content (≥ 75% soluble fiber) best 
recapitulated GI health compared to mice fed GBDs. However, no PD tested recapitulated the 
microbiotas of mice fed GBDs. The creation of PDs with a mixture of soluble and insoluble 













The gut microbiota is a complex and dynamic community of microorganisms—including 
bacteria, archaea, fungi, protists, and viruses—that reside within the gastrointestinal (GI) tract of 
animals1. In contrast to pathogenic microorganisms that cause disease, the gut microbial 
community largely contains symbiotic and commensal microbes, which provide various benefits 
to their host. With 3.8×1013 cells and over 1,900 species residing in the human intestine, bacteria 
comprise the most diverse group of these microorganisms2–4. Therefore, while all members 
contribute to the makeup and function of this community, bacteria are the most extensively 
studied.  
Initially, investigators were restricted to studying the gut microbiota using culture-based 
methods. However, this approach provides limited information because estimates report that only 
10-50% of intestinal bacteria are culturable5. In addition, the costly and time-consuming nature 
of this approach limits the number of samples investigators can analyze. With the reduced cost of 
high throughput sequencing and the advances of -omics technologies (e.g., metabolomics, 
metagenomics, and transcriptomics), researchers are now able to investigate the gut microbiota 
more comprehensively6. These technologies allow researchers to identify the taxonomic 
composition of the majority of microbes within a community, including non-culturable microbes, 
by sequencing microbial genes. Present in all bacteria but not in eukaryotes, the 16S rRNA gene 
is often used in characterizing complex microbial communities and reconstructing 
phylogenies7,8. With conserved regions that are universal across bacteria and variable regions 
that are shared within bacterial groups, the 16S rRNA gene offers sufficient information for 
researchers to identify microbes and to characterize microbial communities. These technological 
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advances have led to seminal discoveries regarding the intricate relationships between the 
intestinal microbiota and human health6. 
The gut microbiota serves numerous functions in the host. For example, the intestinal 
microbiota helps break down nutrients in the intestine, maintains the integrity of the intestinal 
epithelium, and ensures the proper development of the immune system9. The gut microbiota also 
influences the host’s behavior by exerting its effect via the gut-brain axis10. While a healthy gut 
microbiota promotes the health of the host, a disturbed (or dysbiotic) gut microbiota contributes 
to GI dysfunction and factors related to metabolic syndrome (i.e., obesity), inflammatory bowel 
diseases (IBD), and cardiovascular diseases11–14.   
Modulation of enteric microbial communities to restore normal GI functions, with 
probiotics, prebiotics, and fecal microbiota transplantation (FMT), has also been an active field 
of research14. Probiotics are living microorganisms that are beneficial to the host when 
consumed, while prebiotics are non-digestible carbohydrates that selectively promote the growth 
and metabolism of certain beneficial bacteria15. In theory, both probiotics and prebiotics promote 
the restoration of a healthy microbial community; however, more research is required to uncover 
the mechanism and efficacy of treating diseases with probiotics and prebiotics. FMT is a 
procedure where the fecal microbiota from a healthy donor is transferred to a recipient believed 
to harbor an altered gut microbiota16. FMT has shown to be most effective with treating 
Clostridium difficile infection (CDI), with the resolution rate usually higher than 85%16,17. 
However, the efficacy of using FMT to treat IBD, including ulcerative colitis and Crohn's 
disease, has not been promising. The average remission rate is only about 30%, lower than that 
of the current standard IBD treatments18–20. The effectiveness of standard IBD treatments 
coupled with FMT has not been investigated.  
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The composition of the intestinal microbiota is influenced by multiple host factors, 
including diet, age, geographic location, sex, and antibiotic use14,21. Host diet has a significant 
effect on the resulting composition of the microbial community. For example, it was reported 
that short-term consumption of diets composed entirely of animal or plant products rapidly 
altered microbial community structure22. Rodent studies also show that mice fed a high-fat diet 
harbor a gut microbiota distinct from mice fed a low-fat diet23. Further, recent studies have 
demonstrated that supplementing dietary fibers alone significantly alter the microbial 
community, in both human subjects and rodents24,25.   
 
Dietary Fibers and Short Chain Fatty Acids (SCFAs) 
Dietary fibers are carbohydrate polymers that cannot be broken down by human digestive 
enzymes26,27. Fibers therefore escape digestion in the small intestine and pass into the cecum and 
colon, where they become available to the microbial community for fermentation26. There are 
two main types of dietary fibers: water insoluble and water soluble. Insoluble fibers, such as 
cellulose and hemicellulose, are poorly digested by the gut microbiota28. Insoluble fibers increase 
fecal bulking and stool water content in the intestine, resulting in increased GI transit time by 
stimulating mucus secretion and peristalsis29. On the other hand, the viscosity of soluble fibers 
induces gastric distention and slows gastric emptying rate to promote satiety and reduce calorie 
intake29. Recent studies also reveal that the lack of soluble fiber causes microbes to extract 
energy from the colonic mucus, degrading the colonic mucus layer that protects against 
pathogens30,31. Therefore, dietary fibers are essential for maintaining the integrity of the GI tract. 
Soluble fibers, such as inulin, beta-glucans, and pectin, are readily broken down by the 
gut microbiota to produce short-chain fatty acids (SCFAs)28. SCFAs, particularly acetate, 
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propionate, and butyrate, are bacterial metabolites produced from the fermentation of soluble 
fibers and are beneficial to the host. Butyrate is the primary energy source for colonocytes, while 
propionate is a substrate for gluconeogenesis in liver26,30. Colonic delivery of propionate has 
been shown to increase postprandial peptide YY and glucagon-like peptide-1 secretion in 
humans, resulting in reduced food intake32. SCFAs also affect the nervous system. For example, 
acetate crosses the blood-brain barrier and activates hypothalamic neurons to drive satiety33. In 
addition, SCFAs regulate sympathetic nervous system activity via G protein-coupled receptor 41 
(GPR41), allowing control of body energy expenditure by promoting the maintenance of 
metabolic homeostasis34.  
 
Laboratory diets in rodent models 
The two commonly used diet types for rodent models in laboratory studies are grain-
based diets (GBDs) and purified diets (PDs). GBDs, also called chow diets, are produced from 
agricultural and animal by-products, such as ground corn, ground oats, alfalfa meal, soybean 
meal, and ground wheat35. Though they are relatively inexpensive to produce and provide 
adequate nutrition, there are several drawbacks with GBDs in rodent studies. Chow formulas are 
generally “closed” formulas, meaning commercial manufacturers do not disclose the exact 
amount and source of each ingredient35. Even when some diets are open formulas, the 
composition of the components varies with the environmental conditions under which they were 
grown and processed36. The variability of GBDs makes it hard, if not impossible, for researchers 
to accurately report the diet used and to repeat experiments with the same diet. The presence of 
non-nutrients in GBDs, such as heavy metals, also contributes to the difficulty in experimental 
 8 
reproducibility37. These GBD drawbacks also have significant implications regarding gut 
microbiota research, as the complex microbial community is significantly influenced by diet. 
Fortunately, purified diets (PDs), also called purified ingredient diets, are a potential 
solution to these issues. PDs are composed of highly refined ingredients, producing well-defined 
diets with precisely measured amounts of each ingredient and minimal batch-to-batch 
variability36,38. PDs not only increase experimental reproducibility by controlling for a known 
environmental variable, but they also allow researchers to modify any specific ingredient to 
investigate the effects of diets with varying macro- and micronutrient compositions35. 
Unfortunately, most of the currently used PDs, including AIN-76A and AIN-93, contain little or 
no soluble fiber39,40. A recent study by Chassaing et al. showed that the lack of soluble fibers in 
PDs resulted in increased adiposity and abnormal GI anatomy in mice, which were ameliorated 
when inulin, a soluble fiber, was added into the diet41. With the current knowledge on the 
importance of soluble fibers and the recognition of PDs being a powerful tool, PDs containing 
soluble fibers are highly desirable.  
Our goal was to identify a PD with a combination of dietary fibers that promotes the gut 
health of rodents compared to GBDs. The benefit of different fiber mixtures was evaluated by 
the impact of different diets on GI anatomy and the intestinal microbiota composition. This 
project sought to: 1) characterize the gut microbiotas of mice provided six different diet groups 
(two GBDs, four PDs varying in fiber content); 2) compare the microbial communities between 
three distinct GI niches (cecum, colon, and feces); 3) investigate correlations between specific 
microbial taxa and different fiber diets. We hypothesized that diets with a greater mix of soluble 
and insoluble fibers would best promote the gut health of rodents, as a mixture of soluble and 




Six different diets, with similar macro-nutrient contents and essential micronutrients, 
were used in this study. The two GB diets used, Teklad 2020SX from (Envigo; Madison, WI) 
and Purina 5001 (Nestlé Purina PetCare; St. Louis, MO), consisted of unknown dietary fiber 
amounts and compositions. Four purified diets with varying composition of fibers were 
generously gifted from Research Diets (New Brunswick, NJ). Descriptions of the diets, including 
dietary fiber compositions and caloric content, are listed in Table 1. Cellulose is an insoluble 
fiber, while inulin, glucomannan, and pectin are soluble fibers. Since soluble fibers provide 
energy while insoluble fibers do not, the amount of corn starch was slightly adjusted across PDs 
to maintain isocaloric diets. Essential vitamins and minerals were included in all six diets, with 
PDs containing identical amounts. All GBDs and PDs included vitamins A, B1, B2, B3, B5, B6, 
B7, B9, B12, D, E, K, and choline, while Purina also included vitamin C. PDs included calcium, 
phosphorus, sodium, potassium, chlorine, magnesium, sulfur, molybdenum, chromium, copper, 
iron, manganese, iodine, fluorine, selenium, zinc. Teklad included all the minerals above except 
molybdenum and chromium. Purina included all the minerals above except molybdenum, and 













Six-week-old male wild-type (WT) C57BL/6J mice were purchased from Jackson 
Laboratory (Bar Harbor, ME). All animals (n=30 mice) were housed in individually ventilated 
cages with ad libitum access to autoclaved water and food. All autoclaved cages contained 
bedding, a hut, and a nestlet. During the seven-day acclimation period, all mice were fed Teklad 
2020X. Mice were then randomly assigned to one of the six diet groups for 28 days (n=5 
mice/group). Food consumption and body weight were measured on day 0 (when mice were 
placed in individual cages with Teklad 2020SX), on day 7 (when mice were randomly assigned 
to receive one of the six diets), on day 21, and on day 35 (when the study terminated). Food was 
replaced and cages were changed on day 7 and day 21. All animal care and experimental 
protocols were approved by Institutional Animal Care and Use Committee (IACUC) of UNC-
Chapel Hill on protocol 17-136. 
 
Fecal and Tissue Sample Collection 
Fresh fecal pellets were obtained from individual mice on day 0, day 7, day 35. Fecal 
pellets were stored at -20 °C until molecular characterization of microbiotas. Animals were 
sacrificed on day 35 (n=30) by cervical dislocation secondary to isoflurane. Cecal contents and 
colon pellets were collected at tissue harvest, snap frozen in liquid nitrogen, and stored at -80 °C. 
Small intestine length, colon length and weight, cecum weight with content, and gonadal fat 





DNA Extraction  
Bacterial DNA was isolated from fecal pellets, cecal contents, and colon pellets, using a 
phenol-chloroform extraction method followed by a DNA clean-up42. One fecal pellet, two colon 
pellets, or 100-mg of cecal contents, were suspended in 750 µl of lysis buffer (200 mM NaCl, 
100 mM Tris (pH 8.0), 20 mM EDTA, and 20 mg/ml lysozyme) with 300 mg of 0.1 mm glass 
beads (BioSpec, Bartlesville, OK). The mixture was vortexed briefly and incubated at 37 °C for 
30 minutes. For each sample, 85 µL of 10% SDS and 20 µL of Proteinase K (15 mg/mL) from 
the Qiagen DNA Stool Mini Kit (Qiagen, Valencia, CA) was added, and the mixture was 
incubated for another 30 minutes at 60 °C.  
Bacterial cells were physically disrupted by adding 500 µL of 25:24:1 solution of 
phenol:chloroform:isoamyl alcohol and homogenizing in a bead beater (TeSeE Precess 48 
Homogenizer, Bio-Rad, Hercules, CA) for 90 seconds at 5300 rpm. Samples were then 
centrifuged at 13000 rpm for 5 minutes at 20 °C. The resulting supernatant was transferred to 
another 500 µL volume of 25:24:1 phenol:chloroform:isoamyl alcohol, vortexed, and 
centrifuged. The supernatant was then transferred to 500 µL of 100% chloroform, again 
vortexed, and centrifuged. Lastly, the supernatant was transferred to 1 mL100% ethanol with 50 
µL of 3 M sodium acetate. Samples were then stored at -80 °C for 60 minutes to promote DNA 
precipitation. 
Samples were centrifuged at 13000 rpm for 5 minutes at 20 °C. After carefully discarding 
the supernatant, the pelleted DNA was air dried for 5 minutes. The precipitated DNA was 
suspended in 200 µL molecular-grade, nuclease-free water and then cleaned with 100% ethanol 
and buffers (AL, AW1, AW2) from the Qiagen QIAamp DNA Stool Mini Kit per the 
manufacturer’s instructions. NanoDrop (Thermo Fisher Scientific, Madison, WI) was used to 
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quantify the amount and assess purity of final DNA preparations. All samples were diluted to 40 
ng/ml as the working concentration and were stored at -20 °C for subsequent amplification via 
PCR.  
 
Sequencing of 16S rRNA Genes 
Following DNA extraction, two consecutive polymerase chain reactions (PCR) were 
performed to amplify the V4 variable region of 16S rRNA gene. The first PCR contained 120 ng 
of template DNA, six forward primers, six reverse primers (10 µM each primer) and Buffer A, 
Enhancer, dNTPs, and Robust DNA polymerase from the KAPA2G Robust PCR Kit (Kapa 
Biosystems, Wilmington, MA). The mixture was amplified using the following conditions: 
95°C/3min; [95°C/30s; 50°C/30s; 72°C/30s] x 10 cycles; 72°C/5 min; 4°C/hold. The second 
PCR further amplified the V4 variable region and added the Illumina MiSeq adapter primers and 
a single 12-nucleotide Golay error-correcting barcode for multiplexing43. The KAPA HiFi 
HotStart ReadyMix reagent (Kapa Biosystems, Wilmington, MA) was combined with 5 µL PCR 
product from the first reaction, the forward MiSeq adapter primer, and reverse Golay barcode 
primer (10 µM) for the second PCR, using the following parameters: 95°C/3min; [95°C/30s; 
50°C/30s; 72°C/30s] x 22 cycles; 72°C/5 min; 4°C/hold.  
Products from each PCR were purified with the HighPrep PCR clean-up kit (MagBio, 
Lausanne, Switzerland) and a DynaMag-96 side magnet (Life Technologies, Carlsbad, CA) per 
the manufacturer’s instructions. Final purified products for each sample were quantified with a 
NanoDrop (Thermo Fisher Scientific, Madison, WI) and were pooled for sequencing at 
equimolar concentrations. Two pools of amplicons were provided to the High-Throughput 
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Sequencing Facility at UNC School of Medicine for 250bp paired-end sequencing on an Illumina 
MiSeq benchtop sequencer (Illumina, San Diego, CA).  
 
Analysis of 16S rRNA Gene Sequences 
16S rRNA gene forward sequence read classification was performed on Quantitative 
Insights Into Microbial Ecology 2 pipeline (QIIME 2, version 2019.4)44. Single-end reads were 
demultiplexed based on the associated barcode sequence with each sample. Primers and adapters 
were then removed. DADA2 was used to correct for Illumina-sequenced amplicon errors and 
produce sequence variants (SVs) at a 100% identity threshold45. Sequences were truncated at 215 
base pair (bp) for cecal contents, 203 bp for colon contents, 213 bp for fecal samples at day 35, 
and 215 bp for all fecal samples.  
To eliminate rare SVs, SVs with lower than 0.01% of total reads were filtered out for 
each run. Number of SVs decreased from 524 to 321 with a total number of reads of 1,781,133 
after filtering cecal contents. For colon contents, number of SVs decreased from 493 to 318, and 
the number of reads were reduced to 1,826,413. Fecal samples at day 35 had 272 SVs filtered, 
resulting in 358 SVs and 1,787,123 reads. 1086 SVs were filtered out for the run with all fecal 
samples, leaving 379 SVs and 4,885,632 reads. Unfiltered cecal contents, colon contents, and 
fecal samples at day 35 were merged and filtered. The number of SVs decreased from 1647 to 
685, with 5,291,216 reads after filtering. 
At the end of these procedures, 29 cecal samples, 29 colon samples, 30 day 0 fecal 
samples, 27 day 7 fecal samples, and 30 day 35 fecal samples were successfully characterized 
and analyzed.  
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a-diversity, an indication of microbial richness within each group, was characterized with 
Shannon diversity and the absolute number of SVs. b-diversity, representing the differences 
between groups, was characterized with Bray-Curtis dissimilarity. The SILVA classifier (132, 
99% OTUs) was used for taxonomy assignment46. A differential abundance analysis (Analysis of 
Composition of Microbiomes; ANCOM) was used to identify specific genera of bacteria that 
drove differences in the microbial communities between groups across all three sties47. 
 
Statistical Analysis  
After establishing normality with the Shapiro-Wilk test and QQ plots, one-way ANOVAs 
with Tukey post-hoc tests were performed on GraphPad Prism 8 (San Diego, CA) to test for 
statistically significant differences between diet groups for food consumption, body weight 
change, and GI length and weight measurements. Gonadal fat weight measurements did not pass 
the Shapiro-Wilk test for normality, and therefore these data were analyzed with a Kruskal-
Wallis test. Pairwise analysis of similarities (ANOSIM) was used to establish the statistical 
differences based on Bray-Curtis dissimilarity between diet groups and sites. Kruskal-Wallis 
tests were used to test for statistically significant differences between diet groups (at baseline and 
study onset) and sites for Shannon index and the number of SVs. Unpaired t test was used to test 
for statistically significant differences between GBDs and PDs for Shannon index and number of 







Differential effect between GBDs and PDs on food consumption and body weight  
In general, mice fed GBDs (Purina and Teklad) consumed significantly more food than 
mice fed PDs (Fig. 1b-c). Daily calorie intake was calculated (daily food intake × energy 
density) to account for the different calorie density between different diets. Interestingly, calorie 
intake differed between the two GBD groups, Teklad and Purina (Fig. 1d). Mice fed the 75C/25I 
diet also had a higher daily calorie intake than mice fed the 100C and 25C/I/G/P diets (Fig. 1d). 
Consistent with the Chassaing et al. study, we found that a PD without soluble fiber (100C) was 
Fig. 1. Food consumption and body weight changed by diet groups during the study. (a) Timeline of the study. 
Mice were fed Teklad 2020X for 7 days to acclimate, and were randomly assigned to one of the diets for 28 days. 
(b) Cumulative food consumption at day 7 (study onset), day 21, and day 35 (study end). (c) Daily food intake 
from study onset to study end (**p<0.01 vs. Purina). (d) Daily Calorie intake (daily food intake × energy density) 
from study onset to study end (***p<0.001 vs. Purina, except for 75C/25I). (e) Body weight change from study 
onset to study end. (f) Gonadal fat weight at study end. N=5 mice/group. One-way ANOVA with a Tukey post-




associated with increased adiposity, when compared to Purina41 (Fig. 1e,f).  Despite consuming 
more food and calorie, mice fed a Purina diet gained the least weight over the 28-day experiment 
period (Fig. 1e). Consistent with the same study, mice fed 100C had an increased gonadal fat 
weight than mice fed Purina41 (Fig. 1f).  
 
Addition of soluble fibers in PDs differentially impact GI anatomy 
Increased soluble fiber content in PDs was associated with increased small intestinal 
length and cecum weight. The small intestine of mice fed 100C were shorter than those fed 
75C/25I, 25C/75I, and 25C/I/G/P, while mice fed 25C/I/G/P had longer small intestines than 
those fed with all other diets, except for 25C/75I (Fig. 2a, e-j). Mice fed 100C had a lower cecum 
weight when compared to mice fed GBDs, 25C/75I, and 25C/I/G/P (Fig. 2b). 
In addition, mice fed Purina had a higher cecum weight when compared to mice fed all 
the other diets, except for 25C/75I (Fig. 2b). Colons from mice fed Purina weighed more than 
colons from mice fed 100C and 75C/25I (Fig. 2c). No statistically significant differences were 









Fig. 2. GI anatomical measurements at the end of study. (a) Small intestine length (#p<0.05 vs. 25C/I/G/P, except 
for 25C/75I). (b) Cecum weight with contents (#p<0.05 vs. Teklad, except for 75C/25I, *p<0.05 vs. Purina, 
except for 25C/75I, **p<0.01 vs. 75C/25I). (c) Colon weight without contents. (d) Colon length. (e) Small 
intestine of a mouse fed Teklad. (f) Small intestine of a mouse fed Purina. (g) Small intestine of a mouse fed 
100C. (h) Small intestine of a mouse fed 75C/25I. (i) Small intestine of a mouse fed 25C/75I. (j) Small intestine 
of a mouse fed 25C/I/G/P. N=5 mice/group. One-way ANOVA with a Tukey post-hoc test was used to test for 
significance. *p<0.05. **p<0.01. ***p<0.001. 
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No difference in fecal microbiota composition observed between diet groups before diet 
randomization 
We first characterized the fecal microbiotas at day 0 (baseline) and day 7 (study onset) 
(Fig. 3a,d). As expected, no clustering based on diet groups was seen by Bray-Curtis Principal 
Coordinates Analysis (PCoA) plots for day 0 and day 7 (ANOSIM, p>0.1), suggesting that the 
diet group assignments were adequately randomized. Similarly, the two major measures of a-
diversity—Shannon index and number of SVs—showed no significant differences in fecal 
samples at day 0 and day 7 (Fig. 3b,c,e,f).  
 
Fig. 3. Characterization of the microbial communities in fecal sample at baseline (day 0) and study onset (day 7). (a) 
PCoA at baseline. (b) Shannon index at baseline. (c) Number of SVs at baseline. (d) PCoA when study began. (e) 
Shannon index when study began. (f) Number of SVs when study began. N= 5 mice/group.  
 
Within each niche, microbial communities cluster by diet for b-diversity 
Based on Bray-Curtis PCoA, we found distinct clusters of microbial communities 
between diets at day 35 (study end) in all three GI niches (Fig.4 a-c). The microbial communities 
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in the cecum were significantly different between diet groups (ANOSIM, p<0.05 between all 
groups, except for 25C/75I vs. 25C/I/G/P, 25C/75I vs. 75C/25I) (Fig. 4a). Characterization of 
microbial communities in the colon and feces produced similar results (Fig. 4b,c). Interestingly, 
the microbial communities in mice fed 100C clustered distinctly (as Fig. 4a black circle 
indicates), whereas the microbial communities in mice fed GBDs separated from those fed PDs 
(as Fig. 4a blue circle indicates) (ANOSIM, p<0.001 between GBDs and PDs). In addition, mice 
fed low soluble fiber PDs (100C and 75C/25I) produced significantly different microbial 
communities than mice fed high soluble PDs (25C/25I and 25C/I/G/P) (ANOSIM, p<0.001). 
These results indicated that within each GI niche, microbiotas clustered separately by diet.  
 
Fig. 4. PCoA showing the microbial composition by diet groups in cecum, colon and feces at the end of the study 
(day 35). (a) Microbial communities in cecal content by diet group. (b) Microbial communities in colon content by 
diet group. (c) Microbial communities in fecal sample by diet group. N= 5 mice/group. ANOSIM was used to test 
for significance.  
 
Impact of diet on microbial richness (a-diversity) was consistent with b-diversity measures 
Microbial richness in GBDs was significantly higher than that in PDs across all three GI 
sites (Fig. 5a-f). In addition, increased soluble fiber was associated with decreased a-diversity in 
both number of SVs and Shannon index. Mice fed high soluble fiber PDs (25C/25I and 
25C/I/G/P) had a significantly lower a-diversity than mice fed low soluble PDs (100C and 





Fig. 5. a-diversity in cecum, colon, and feces by diet group at the end of the study (day 35). (a) Shannon index of 
cecal samples between diets. (b) Shannon index of colon samples between diets. (c) Shannon index of fecal samples 
between diets. (d) Number of SVs in cecum between diets. (e) Number of SVs in colon between diets. (f) Number 
of SVs in feces between diets. (g) number of SVs in cecum between GBDs (Teklad and Purina), low soluble fiber 
PDs (100C and 75C/25I), and high soluble fiber PDs (25C/75I and 25C/I/G/P). (h) number of SVs in colon between 
GBDs (Teklad and Purina), low soluble fiber PDs (100C and 75C/25I), and high soluble fiber PDs (25C/75I and 
25C/I/G/P). (i) number of SVs in feces between GBDs (Teklad and Purina), low soluble fiber PDs (100C and 
75C/25I), and high soluble fiber PDs (25C/75I and 25C/I/G/P). N=5 mice/group. One-way ANOVA with a Tukey 
post-hoc test was used to test for significance. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001.  
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Microbial communities did not cluster by GI niche 
PCoA revealed clustering of microbial communities between cecum and colon, cecum 
and feces (ANOSIM, p<0.005), but not between colon and feces (Fig. 6a). Two measures of a-
diversity—Shannon index and number of SVs—also indicated no significant differences in 
microbial richness between niches (Fig. 6b,c). Consistent with previous results, microbial 
communities clustered based on diets after merging samples from all three GI sites (Fig. 6d). 
These data illustrated that diet exerted a strong influence on shaping the microbial communities.  
 
Fig. 6. Characterization of microbial communities in the cecum, colon, and feces at the end of study (day 35). (a) 
PCoA plot (Bray-Curtis) of microbial communities from the cecum, colon, and feces. p<0.005 between cecum and 
colon, and between cecum and feces. No significant difference between feces and colon. (b) Shannon index across 
three GI sites. (c) Number of SVs across three GI sites. (d) microbial communities clustered according to diet. 
ANOSIM was used to test for significances for b-diversity. One-way ANOVA was used to test for significance for 
a-diversity. N=29 for cecum, n=29 for colon, and n=30 for feces.  
 
Lactococcus species drove differences in microbiotas between PDs and GBDs  
Lastly, we performed a differential abundance analysis (ANCOM) to identify specific 
genera of bacteria that drove differences in the microbial communities between diet groups 
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across all three sties (Fig. 7a). The relative abundance of Lactococcus spp. was differentially 
higher in the cecum, colon, and feces of mice fed PDs than in mice fed GBDs (Fig. 7b). 
[Eubacterium] ventriosum group was mostly found in the cecum and feces of mice fed the 
Teklad diet (Fig. 7c). Mice that consumed a Purina diet had a higher relative abundance of 
Tyzzerella 3 spp. in the cecum and feces, when compared to all other groups (Fig. 7d). The 
relative abundance of Romboutsia spp. were also higher in the cecum and colon of mice fed 
75C/25I and 100C than other groups (Fig. 7e). Akkermansia spp. were more abundant in the 
cecum of mice fed PDs, while [Eubacterium] xylanophilum group were more abundant in the 
cecum of mice fed GBDs (Fig. 7f-g).  
 
Fig. 7. Specific bacterial genera identified with a differential abundance analysis (ANCOM). (a) Significant genera 
identified across the three GI sites. (b) Log10 relative abundance of Lactococcus spp. in cecum. (c) Log10 relative 
abundance of [Eubacterium] ventriosum group in cecum. (d) Log10 relative abundance of Tyzzerella 3 spp. in 
cecum. (e) Log10 relative abundance of Romboutsia spp. in cecum. (f) Log10 relative abundance of Akkermansia spp. 






Consistent with the Chassaing et al. study, our data found that the PD lacking soluble 
fibers (100C) resulted in significantly increased gonadal fat weight (a standard measure for body 
adiposity) and decreased colon weight, when compared to a specific GBD, Purina 500141. 
However, as this previous study only used Purina 5001 as the GBD, we also evaluated the effect 
of a second GBD (Teklad 2020SX) on GI anatomy. Unexpectedly, unlike Purina 5001, mice that 
consumed the Teklad 2020SX diet did not exhibit significantly different gonadal fat or colon 
weights, when compared to the PDs. In addition, GBDs and PDs produced significantly different 
microbial communities in mice. Even within GBDs, the microbial communities clustered 
distinctly between Teklad and Purina.  
These results suggest that using a GBD as a control for rodent studies is not reliable and 
decreases the generalizability of results. Such variability highlights the importance of using PDs 
for rodent studies, yet, many studies investigating the effect of high-fat diets (HFD) on the gut 
microbiota continue to use GBDs, instead of low-fat PDs, as controls48,49,50. A recent study 
demonstrated that the lack of soluble fiber in PDs, instead of the addition of fat, drove 
alternations in the gut microbiota of mice48. Moreover, another study reported that the microbial 
communities between mice fed GBDs and PDs were more distinct than those between mice fed a 
high-fat PD and a low-fat PD51. Consistent with these findings, our study also illustrated that 
GBDs are unreliable controls, as mice fed GBDs produce distinct microbial communities when 
compared to those fed PDs.   
 As the amount of soluble fibers in PDs increased, the small intestine length, cecum 
weight, and colon weight increased. Again, consistent with the Chassaing et al. study, the 
 25 
addition of soluble fiber to PDs promoted these GI anatomical measurements, which are usually 
associated with healthier GI functions41. Unexpectedly, the addition of soluble fibers in PDs led 
to decreased a-diversity—a measurement of microbial richness—of the gut microbiota. 
Decreased a-diversity has typically been associated with a low-fiber high-sugar diet and linked 
to metabolic syndromes and IBD in human and mouse studies52. Additionally, a study showed 
that piglets fed a diet with only soluble fiber had a significant increase in a-diversity, when 
compared to piglets fed a baseline diet, a diet with only insoluble fiber, or a diet with a mixture 
of soluble and insoluble fiber53. Yet, it was also recently reported that soluble fiber interventions 
in human studies did not result in a difference in a-diversity, when compared to the control 
group with no additional soluble fiber27. It was therefore unexpected that the addition of soluble 
fibers to rodent diets was beneficial to the GI tract (based on gross anatomy) yet accompanied 
with a decreased a-diversity. One hypothesis to explain this finding is that more bacterial groups 
are needed to break down the insoluble fiber to extract energy, thus increasing the number of 
different microbes in the gut. Future studies are needed to validate this hypothesis and to uncover 
a potential mechanism. 
 Though the validity of using fecal samples—as opposed to cecal or colon contents—to 
represent the gut microbiota has been questioned, our study showed similar clustering by diet 
groups across three GI sites on PCoA plots54. While we did find separate clustering between 
fecal and cecal microbiotas, the microbiotas clustered more distinctly by diet groups irrespective 
of the GI niche, suggesting that diet plays a more significant role in driving the microbial 
composition. However, recent studies also suggest that mucosa-associated microbiota is a more 
accurate representation of the intestinal microbiota than luminal microbiota, as mucosa-
associated microbiotas directly interact with intestinal epithelial cells and enterocytes55,56. These 
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studies also reported that luminal microbiotas were not distinct between sites, but the mucosa-
associated microbiota was distinct from luminal ones and exhibited greater associations with 
certain diseases, such as Crohn’s disease56. The mucosa-associated microbiotas were not 
characterized in our study, but represents an important future direction.  
 Lactococcus spp. had a higher relative abundance in mice fed PDs than in mice fed GBD. 
It has been reported that the presence of Lactococcus spp. in rodent gut microbiota resulted from 
contamination in PDs51,57,58. Specifically, Lactococcus spp. are involved in industrial production 
of casein, which is the main protein source in PDs but not in GBDs. As high throughput 
sequencing of the 16S rRNA gene is unable to distinguish between live and dead microbes, it is 
difficult to determine the source of Lactococcus spp. in our study. In an independent study, 
investigators concluded that the Lactococcus spp. detected in their fecal samples originated from 
dead bacteria DNA leftover from casein production as they were unable to culture viable 
bacteria, yet detected Lactococcus spp. in the diet57. Since we did not perform these experiments 
in our study, we cannot conclude that the Lactococcus spp. found in PDs were leftover DNA 
from casein production, but it is a potential explanation for this increased abundance in the PDs 
compared to GBDs.  
Limited research has been carried out to investigate the role of [Eubacterium] ventriosum 
group and Tyzzerella 3 spp. in the gut microbiota. More studies are needed to help explain why 
the [Eubacterium] ventriosum group was more abundant in mice fed Teklad and why Tyzzerella 
3 spp. was more abundant in mice fed Purina, when compared to other diet groups in our study. 
Romboutsia spp. have incredible metabolic capabilities, including the ability to ferment 
carbohydrates, glycerol, and amino acids59. This interesting feature might help explain the high 
relative abundance of Romboutsia spp. in mice fed low soluble fiber PDs. It is also consistent 
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with the hypothesis that increased types of bacteria are needed to utilize low soluble fiber in PDs, 
which results in a higher a-diversity.  
Akkermansia spp. are mucin-degrading bacteria that reside in the mucus layer in the 
intestine. Mucin constitutes carbon and energy sources that can be released and used by the gut 
microbiota when broken down by mucin-degrading bacteria60. Increased relative abundance of 
Akkermansia spp. is associated with reduced mucosa inflammation and an increased metabolic 
profile61. As Akkermansia spp. had a higher relative abundance in PDs than in GBDs, our study 
suggests that the PDs may promote an anti-inflammatory environment in the gut. 
[Eubacterium] xylanophilum was found to be able to break down xylan, which is a 
hemicellulose62. A recent study also found that the relative abundance of [Eubacterium] 
xylanophilum increased when cultured inoculants supplemented with wheat barn63. 
Unsurprisingly, [Eubacterium] xylanophilum was more abundant in GBDs, in which xylan was 
likely present as an agricultural byproduct, than in PDs, where xylan was not present. 
In conclusion, mice fed PDs with high soluble fiber content (≥ 75% soluble fiber) best 
recapitulated GI health compared to mice fed GBDs, but we did not find any PD that 
recapitulated the gut microbiota of mice fed GBDs. Furthermore, GBDs are unreliable choices as 
controls in diet-based studies because of their variable impact on host anatomy and gut 
microbiota. Therefore, the creation of PDs with a mixture of soluble and insoluble fibers is 
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